(Q41665387)

6 October 2017

1 reference

title

New approaches to pain control in patients with cancer (English)

1 reference

6 October 2017

1

1 reference

6 October 2017

publication date

1 July 1997

1 reference

European Journal of Cancer

6 October 2017

published in

1 reference

6 October 2017

volume

33 Suppl 6

1 reference

6 October 2017

page(s)

S8-14

1 reference

Prevalence of symptoms among patients with advanced cancer: an international collaborative study. Symptom Prevalence Group.

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900205-0

7 January 2021

Recent clinical trials of pain control: impact on quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900205-0

7 January 2021

The role of bisphosphonates in the treatment of bone metastases--the U.S. experience

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900205-0

7 January 2021

Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900205-0

7 January 2021

A regional survey of opioid use by patients receiving specialist palliative care

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900205-0

7 January 2021

Randomized evaluation of controlled-release codeine and placebo in chronic cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900205-0

7 January 2021

An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900205-0

7 January 2021

Opioid rotation for toxicity reduction in terminal cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900205-0

7 January 2021

Attenuation of morphine-induced delirium in palliative care by substitution with infusion of oxycodone.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900205-0

7 January 2021

A randomized, crossover evaluation of methylphenidate in cancer patients receiving strong narcotics

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900205-0

7 January 2021

Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900205-0

7 January 2021

Psychostimulants as adjuvant analgesics

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900205-0

7 January 2021

Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900205-0

7 January 2021

Anticonvulsant drugs for management of pain: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900205-0

7 January 2021

Use of nonsteroidal anti-inflammatory drugs in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900205-0

7 January 2021

Ketorolac continuous infusion: a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900205-0

7 January 2021

Ketamine: its mechanism(s) of action and unusual clinical uses.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900205-0

7 January 2021

Endpoints in cancer clinical trials: is there a need for measuring quality of life?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900205-0

7 January 2021

10.1016/S0959-8049(97)00205-0

Identifiers

DOI

1 reference

6 October 2017

1 reference